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Introduction
Skeletal muscle tissue has a remarkable capacity to regen-
erate due to the potential of the myogenic stem cell, the 
satellite cell. Upon injury, quiescent muscle stem cells are 
activated, enter the myogenic program, and begin to prolif-
erate. When the myoblasts later differentiate, they are able 
to fuse with already existing myofibers or fuse and form 
polynucleated myotubes that afterwards differentiate into 
mature myofibers, thereby restoring the muscle.1 These 
characteristics make the satellite cell the primary candi-
date for use in muscle repair.
Strategies for stem cell therapy must deal with both 
type and size of muscle damage. Thus, small or diffuse 
lesions and volumetric loss should be handled differently. 
For small and diffuse lesions, cell delivery by injection has 
been employed and is clinically well accepted because of 
the minimal invasiveness of this technique.
Cultured myoblasts have been injected and studied for 
their regenerative potential in several types of lesions, 
reviewed by Ciecierska et al.2 However, effective clinical 
procedures for repair of skeletal muscle tissue are not yet 
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available because of low transplantation efficiencies, 
reviewed in Sicari et al.3
In generalized muscular dystrophy, myoblast implan-
tation by injection has been studied in animal models,4,5 
as well as in human trials.6,7 While results in animal 
models were promising, most clinical trials turned out 
disappointing.
However, clinical trials on the treatment of inconti-
nence by implantation of cells in the urethral sphincter 
wall have been more successful.8–12 Likewise, animal 
models for incontinence13–15 show that the continence 
improves following implantation of various cell types, but 
still histological examinations reveal a low recovery of 
implanted cells.
A major problem thus appears to be the survival in the 
tissues of injected myoblasts.16 The injection procedure 
has been shown to be harmful, exposing the cells to 
mechanical forces17 and oxidative stress.18 Furthermore, 
the innate inflammatory response at the site of implanta-
tion19–21 has been considered to have adverse effects on 
implanted cells.
The use of injectable scaffolds to deliver myoblasts 
for regenerative medicine applications could be part of a 
solution. Such scaffolds can potentially reduce the shear 
force during injection17 and possibly protect the cells 
against inflammatory host response, and thereby improve 
cell survival.22 Further advantages in the use of injecta-
ble scaffolds could be the possibility to obtain a local-
ized deposition of cells in the region of interest, and to 
obtain a local concentration of myoblasts in close prox-
imity, permitting their subsequent fusion to form fibers. 
Also, injectable scaffolds have been shown to be effec-
tive for local delivery of bioactive components 
that support the implanted cells and optimize the 
micro-environment.
An additional parameter in optimizing implantation of 
myoblasts could be the selection of cells in specific states. 
In this study, we examined the cell responses induced by 
exposure to fibrin, alginate, and poly(lactic-co-glycolic 
acid) (PLGA): three Food and Drug Administration 
(FDA)-approved, injectable materials previously used for 
clinical purposes.23–25 We demonstrated in vitro how these 
scaffold materials differ in their regulation of the myo-
genic program.
Materials and methods
Isolation and propagation of human myoblasts
Human myoblasts were isolated from biopsies taken from 
young men (20–25 years). We established human primary 
myoblast cultures as previously described.26,27 In short, 
muscle biopsies were obtained from m. vastus lateralis, 
freed from connective tissue, minced, washed, and dissoci-
ated with 0.05% trypsin–ethylenediaminetetraacetic acid 
(EDTA; Invitrogen) for 3 × 30 min. Harvested mononuclear 
cells were pooled, and fetal bovine serum (FBS; Invitrogen) 
was added as protease inhibitor.
To obtain a myoblast-enriched cell culture, the cells 
were preplated in non-coated dishes to reduce the fraction 
of fibroblasts. We seeded isolated cells (maximum five 
passages) on flasks (NUNC) coated with extracellular 
matrix gel (from Engelbreth-Holm-Swarm mouse sar-
coma; Sigma–Aldrich), and during every passage, the cells 
were preplated for 20–30 min before transfer to Dulbecco’s 
Modified Eagle Medium (DMEM) with 10% FBS and 1% 
penicillin and streptomycin (PS; Invitrogen).
In each experiment, we used cells from three individu-
als. The procedure was approved by The Regional Ethical 
Committee of Southern Denmark (S-20070079).
Cultivation of myoblasts in fibrin and alginate 
gels
Alginate. The alginate used in the study was LVG alginate 
(Novamatrix), a low-viscosity gel composed of a mini-
mum 60% guluronate. A number of 6 × 105 primary human 
myoblasts were mixed with 600 µL of sterile 1% LVG 
alginate solution in phosphate-buffered saline (PBS) at 
room temperature. We released 25 µL alginate into a 100-
mM CaCl2 solution for 60 s to produce polymerized algi-
nate spheres.
Fibrin. A number of 6 × 105 primary human myoblasts were 
dissolved in 300 µL of human plasma. A volume of 300 µL 
of bovine thrombin (100 U/mL in isotonic NaCl; Biofac 
A/S) was added and incubated for 30 min at 37°C. The 
resulting gel was cut into six equal portions.
The alginate and fibrin gels were rinsed twice in sterile 
PBS and transferred to 24-well plates. Each gel was placed 
in a well containing 0.5 mL growth medium (GM) (DMEM 
with 2% Ultroser G (Pall Life Sciences), 2% FBS, and 1% 
PS) and incubated at 37°C and 5% CO2 in a humidified 
incubator. GM was renewed every second day.
After 7 days in GM, the medium was changed to dif-
ferentiation medium (DM) (DMEM with 2% FBS, 1% PS, 
and 25 pmol insulin (Actrapid; Novo Nordisk)) to induce 
differentiation.28
Gels incubated in GM at day 1 and day 4 and gels incu-
bated in DM at day 14 were harvested for paraffin embed-
ding for histology.
Cell retrieval from degraded alginate and fibrin 
gels
Each gel was placed in a well (24-well plate) containing a 
12-mm circular glass coverslip (Menzel) at the bottom. 
Cells released passively during cultivation due to degrada-
tion of the gels were allowed to attach to the coverslip, and 
when growth was observed in all wells, medium was 
changed from GM to DM to induce differentiation.
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Cell retrieval from dissolved alginate gels
To obtain fast and synchronous cell retrieval, sodium cit-
rate buffer, acting as calcium chelator, was employed to 
dissolve the alginate gels. After 4 days of incubation in 
GM, each gel was dissolved in 100 µL isotonic solution of 
50 mM trisodium citrate dihydrate (Sigma–Aldrich) and 
104 mM NaCl (Sigma–Aldrich), pH 8.0 at 37°C. After 
10 min, 900 µL of GM was added.
For the study of proliferation, cells retrieved from one 
gel were equally distributed to four wells in a 24-well 
plate, and cultured with coverslips in 0.5 mL GM for 
1–4 days.
For the study of differentiation, cells from one gel were 
distributed to two wells containing 0.5 mL GM for 2 days, 
and then in 0.5 mL DM for 5 days.
Cultivation of myoblasts on PLGA-based 
microparticles
PLGA-based spherical microparticles, 10–100 µm in 
diameter, were used for the study (a gift from Coloplast 
A/S). For details on manufacturing, see Wen et al.29
Before culturing, the microparticles were washed in 
12% ethanol. A number of 10,000 primary human myo-
blasts were cultured with 1.5 mg microparticles in ultra-
low attachment culture dishes (60 mm; Corning) for 7 days 
before changing to DM for another 7 days. The harvested 
microparticles were spun down to a pellet and embedded 
in paraffin.
Paraffin embedding procedures
Standard procedure for paraffin embedding results in dis-
solution of alginate, and PLGA microparticles and thus 
loss of cells. Consequently, to enable later sectioning of 
alginate gels and microparticle-cell aggregates from paraf-
fin blocks, the harvested materials were infiltrated with 
plasma and thrombin for 30 min and then fixed in 4% neu-
tral buffered formalin (NBF), followed by paraffin embed-
ding. This initial fibrin embedding trapped the cells in their 
position in alginate and on particles, respectively.
Immunocytochemical staining
Immunocytochemistry was performed on either 3 µm sec-
tions from formalin fixed, paraffin embedded specimens or 
on cultured myoblasts on coverslips. Staining was per-
formed on a Ventana BenchMark immunostainer (Roche) 
with the OptiView-DAB detection system. Before staining 
of cytological preparations, the coverslips were mounted 
on glass slides. The primary antibodies used were anti-
CD56 (neural cell adhesion molecule (NCAM)):MRQ-42 
(NCAM), rabbit monoclonal (Cell Marque), anti-myo-
genin: F5D, mouse monoclonal (Ventana Medical Systems), 
Ki67: CONFIRM anti-Ki-67 (30-9) rabbit monoclonal 
(Ventana Medical Systems), anti-MHCfast: Anti-Myosin 
(Skeletal, Fast) antibody, mouse monoclonal, and clone 
MY-32 (Sigma–Aldrich).
Phalloidin staining
Paraffin sections of alginate and fibrin gels were deparaffi-
nized and incubated with phalloidin 1:40 conjugated to 
Alexa fluor 546 (Life Technologies) in Dako dilution 
buffer for 1 h at room temperature and dark conditions, 
then rinsed 3 × 10 min in Tris-buffered saline (TBS). The 
mounting medium (Vectashield) contained DAPI 
(4′,6-diamidino-2-phenylindole) to visualize nuclei.
Fixation and processing of microparticles and 
cells for electron microscopy
Transmission electron microscopy. Microparticles cultured 
with proliferating myoblasts were spun down to a pellet 
and resuspended in 2% glutaraldehyde in 0.04 M phos-
phate buffer, pH 7.4 for 60 min at 20°C. The cells were 
spun down again and washed in 0.1 M phosphate buffer 
for 10 min. The pellet was resuspended in 15% bovine 
serum albumin (BSA) for 60 min at 20°C, and then incu-
bated in 2% glutaraldehyde over night at 4°C to solidify.
Following rinsing, the solidified material/pellet was 
post-fixed with 1% osmium tetroxide in 0.1 M phosphate 
buffer for 60 min at 4°C, dehydrated through a graded 
series of alcohol and acetone at 4°C–20°C, and infiltrated 
in Epon for 90 min at 20°C. Ultra-thin sections were cut 
from the Epon block on a Leica Ultracut UCT ultrami-
crotome (Rowako AB), contrasted with uranyl acetate and 
lead citrate, and examined and photographed in a precali-
brated Philips EM 208 electron microscope and a 
Megaview III FW camera (both FEI Company).
Scanning electron microscopy. Microparticles cultured with 
proliferating myoblasts were dried, spread out on a metal 
specimen stub, and gold coated by sputter coating before 
imaging using a scanning electron microscope (Hitachi 
TM3000 Tabletop scanning electron microscope).
Quantitation
The Ki67 index was calculated from counting of cells on 
scanned images (NanoZoomer 2.0-HT digital Slide 
Scanner and NDP.view2 software; Hamamatsu) of the 
stained coverslips. The entire coverslip was scanned, and 
because the coverslip is round, the orientation in the 
images are random. From each culture, pictures (10× mag-
nification, field: 1240 × 697 µm2), covering the entire hori-
zontal diameter, were imported to ImageJ.30 Using the Cell 
Counter plugin, the cells were counted in all imported pic-
tures or in every second picture when the amount of cells 
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was high. More than 200 cells were counted, except for 
one culture at 24 h where only 134 cells were found in the 
horizontal diameter zone.
Results
We cultured primary human myoblasts, isolated from 
young men, with three types of scaffolds to examine the 
influence on proliferation and differentiation of myoblasts 
of the different materials. As a model for testing, the cell 
instructive effect in the selected materials, we produced 
25–50 µL portions of gel, each containing in the range of 
25,000–50,000 cells.
In standard monolayer culture, the DM in 4 days is 
able to induce differentiation of confluent myoblasts and 
consequently cease most proliferation.28 According to 
this, proteins expressed during myogenesis was exam-
ined with immunohistochemistry in proliferating cells at 
days 1 and 4, and in differentiating cells at days 5–7 after 
change to DM. Ki67, which is only expressed in prolifer-
ating cells,31 was used as a marker for proliferation. We 
used myogenin and MHCfast as an early marker and a 
late marker of differentiation, respectively. NCAM is 
constitutively expressed by myoblasts and myotubes, and 
was used as a marker for myoblasts and immature fibers. 
The vast majority of the cells in both the proliferating and 
differentiating cultures were NCAM positive as seen in 
Figure 1(c) and (d).
Fibrin gel
Proliferating myoblasts embedded in fibrin gel and cul-
tured in GM appeared spindle shaped after 24 h, and the 
majority of the cells were proliferating and expressing 
Ki67 (Figure 1(a)). After 4 days, Ki67 was lost in the cen-
tral part of the gels, but positive cells were still present in 
the periphery of the gel where the surface was exposed to 
the medium (Figure 1(b)). In contrast, myoblasts situated 
inside the fibrin gel at day 4 in GM had initiated a sponta-
neous differentiation, forming myotubes and expressing 
myogenin and MHCfast (Figure 1(e) and (g)). To opti-
mize conditions for differentiation, the fibrin gels were 
then placed in DM for 7 days. Under these conditions, the 
differentiation was further enhanced (Figure 1(f) and (h)), 
but still a few superficial Ki67-positive cells were seen 
(not shown). In conclusion, embedding myoblasts in the 
fibrin gel induced fast differentiation. However, at the 
interface to culture medium, cells retained their capacity 
to proliferate.
Alginate gel
Myoblasts embedded in alginate gel quickly obtained a 
round shape and remained round without cell extensions at 
all time points examined (Figure 2(a)–(h)). After 1 day of 
culture in GM, the alginate embedded myoblasts still 
expressed Ki67 (Figure 2(a)), but after 4 days, they had 
exited cell cycle, and very few Ki67-positive cells were 
seen (Figure 2(b)). No signs of differentiation were found 
after 4 days in GM (Figure 2(c) and (e)), and even the 
standard procedure to induce differentiation, by changing 
to DM, did not produce multinucleated myotubes or induce 
expression of myogenin and MHCfast (Figure 2(d) and 
(f)). The phalloidin stain visualizing the actin cytoskeleton 
(Figure 2(g) and (h)) confirmed that the cells were rounded 
up and did not have extensions. Thus, the present formula-
tion of LVG alginate hydrogel induced myoblasts to exit 
the cell cycle and enter quiescence. Moreover, alginate 
kept the myoblasts resistant to induction of differentiation 
by DM.
PLGA microparticles
When myoblasts were cultured with PLGA particles, 
ranging in diameters from 10 to 100 µm, a single myo-
blast could attach to the surface of several microparti-
cles, hence aggregates of microparticles held together by 
myoblasts were formed (Figure 3(a) and (b)). Culturing 
myoblasts with microparticles promoted proliferation, 
seen as continued expression of the Ki67 at day 4 in GM 
(Figure 3(c)). Even when exposed to DM for 7 days, the 
amount of Ki67 expressing cells was prominent (Figure 
3(d)). However, markers for differentiation were 
expressed by a few scattered myoblasts in GM day 4 
(Figure 3(e) and (g)). When cultured in DM, a small 
population of mononuclear cells expressed myogenin, 
and a small number expressed MHCfast indicating some 
degree of differentiation, though multinucleated myo-
tubes remained scanty (Figure 3(f) and (h)). This sug-
gests that culturing myoblasts on PLGA microparticles 
favors proliferation and inhibits differentiation. The con-
tact with PLGA even counteracted the induced 
differentiation.
Cells retrieved from alginate and fibrin gels
A prerequisite for successful integration of transplanted 
myoblasts is that they retain their ability to fuse and form 
new myofibers. We examined the ability of myoblasts 
released from alginate and fibrin to proliferate and differ-
entiate outside the gels.
Cells were continuously released from the surface of 
the alginate and fibrin gels to the culture medium. We col-
lected cells for 9 days by letting the released cells attach to 
a cover slip and grow in GM. The vast majority of released 
cells were still the NCAM-positive myogenic cells (Figure 
4(a)–(d) and (g)). Cells retrieved from the gels in this way 
were able to both proliferate, and after induction by DM, 
differentiate into multinucleated myotubes (Figure 4(a)–
(f)). The cells retrieved from alginate gels were observed 
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to form larger fibers containing more nuclei than those 
retrieved from fibrin gels (Figure 4(c) and (d)).
In an additional experiment, we dissolved alginate gels 
by adding sodium citrate buffer, a calcium chelator. This 
resulted in a fast dissolution of the gel and retrieval of 
cells, which were later able to differentiate in DM (Figure 
4(g)). When the cells were cultured in GM, we could dem-
onstrate that about 20% of the cells within 24 h entered 
cell cycle and the expression of Ki67 rose between 24 and 
72 h after release to around 90%, thus indicating that the 
cells were synchronously reactivated from quiescence 
(Figure 4(h)).
Discussion
In the present in vitro study, we demonstrated that the 
injectable scaffold materials, fibrin, LVG alginate, and 
PLGA-based microparticles, all influenced the cell state 
Figure 1. Proliferating human myoblasts embedded in fibrin gels, cultured in growth medium (GM) for 7 days and then in 
differentiation medium (DM) for another 7 days. The immunostaining for Ki67 at (a) day 1 shows a uniform distribution of Ki67-
positive cells throughout the gel. (b) Day 4 Ki67-positive cells are mainly located at the surface. The vast majority of cells are 
positive for the myoblast marker NCAM at (c) day 1 and (d) day 4. At day 4 in GM, spontaneous formation of myotubes was 
detected, as well as expression of (e) myogenin and (g) MHCfast. More myotubes were detected in DM at (f, h) day 14 and with 
more nuclei per tube. During the experiment, the fibrin gels decreased in size and turned into more compact pellets. Scale bars for 
(a) and (b) represent 1 mm, and 100 µm in the insets. Scale bars for (c)–(h) represent 100 µm.
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of primary human myoblasts; however, they had differ-
ent cell instructive effects resulting in promotion of dif-
ferentiation, quiescence, and proliferation, respectively 
(Table 1).
Moreover, we showed that the myoblasts during contact 
with or after retrieval from the three materials retained the 
capacity for proliferation and differentiation.
Concerning particularly alginate, it has been reported 
that also C2C12 mouse myoblasts survive embedding, 
while, in contrast, olfactory ensheathing cells did not.32 
The survival of cells embedded in alginate thus appears to 
be cell-type dependent.
The nature of lesions, that could be candidates for treat-
ment with myoblast transplantation, includes both localized 
Figure 2. Proliferating primary human myoblast embedded in 1% LVG alginate gel spheres. The spheres were placed in growth 
medium (GM) for 7 days and then in differentiation medium (DM) for another 7 days. (a) At day 1, most myoblasts were positive 
for Ki67, (b) but at day 4, this expression had ceased. Neither did the cells express markers for differentiation, (c) MHCfast and (e) 
myogenin. (d, f) Exposure to DM did not induce expression of differentiation markers. Accordingly, the phalloidin staining showed 
a round morphology of the cells at both (g) day 4 in GM and (h) day 14 in DM. Scale bars for (a)–(f) = 100 µm, (g) = 200 µm, and 
(h) = 10 µm.
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acute and chronic lesions with or without fibrosis, as well as 
atrophy and more diffused degeneration. Therefore, the 
option to choose different priming of the myogenic cells 
could be valuable in approaches to develop protocols for 
implantation of myogenic cells.
Fibrin is widely used clinically for surgery as a tissue 
sealant. It is produced by thrombolytic cleavage of fibrin-
ogen. In vivo, it is rapidly degraded but the degradation 
rate of fibrin gel can be modulated by change in the con-
centration of fibrinogen.33 The fibrin gel used in this study 
Figure 3. Human myoblasts were cultured with microparticles in growth medium (GM) for 7 days before changing to differentiation 
medium (DM) for another 7 days. (a) Transmission electron microscopy (TEM) shows a myoblast joining together two microparticles. 
The myoblasts attach to the microparticles by growing into cavities in the particle surface (arrow). (b) Scanning electron microscopy 
(SEM) shows proliferating myoblasts adhering to and joining the particles. In the paraffin-embedded aggregates, the PLGA-based 
material melts during processing leaving empty gabs (*). (c) The majority of cells were Ki67 positive at day 4 in GM, and (d) even 
after changing to DM, Ki67 expression was seen in part of the cells. (e) In GM day 4, some myogenin-positive cells were seen and (f) 
culture in DM only slightly increased the expression. (f, inset) Mainly mononuclear cells were stained, although a few myofibers were 
detected. (g, h) The same pattern was observed in the MHCfast staining. Scale bars for (a) = 5 µm, (b) = 50 µm, and (c)–(h) = 100 µm.
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was prepared from human blood plasma. This can be 
favorable for clinical purposes because of the possibility 
to use autologous plasma for fibrin scaffolds. This con-
centration of fibrin, approximately 3 mg/mL has also 
Figure 4. Cells spontaneously retrieved from alginate and fibrin gels. Proliferating primary human myoblasts were embedded in 
alginate and fibrin gels and placed in growth medium (GM) for 9 days. During this period, the gels were partly dissolved resulting in 
cell release. In both (a, c) alginate and (b, d) fibrin, the majority of released cells were NCAM positive and (e, f) formation of MHCfast-
positive myotubes could be found after induction of differentiation with differentiation medium (DM). For induced retrieval of cells 
from alginate gels, myoblasts embedded in alginate gels were placed in GM for 4 days and then the cells were retrieved by dissolving the 
gel by sodium citrate buffer. (g) Retrieved cells cultured in GM for 2 days followed by DM for 5 days showed strong NCAM positivity 
with myotube formation. In retrieved cells, cultured in GM for 1–4 days, (h) the Ki67 labeling index showed synchronous reactivation 
(n = 3). Scale bars for (a), (b), and (g) represent 500 µm and scale bars for (c) and (d) represent 100 µm.
Table 1. Cell instructive properties of injectable scaffold materials.




Alginate gel +++ – – –
Fibrin gel – + ++ +++
Microparticles – +++ – +
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previously been found preferable compared to higher 
concentrations.33
Myoblasts have previously been cultured with fibrin in 
vitro,34 and fibrin has been shown to improve the survival 
and integration of primary rat myoblasts injected into skel-
etal muscle tissue.33,35
In a study, primary human myoblast cultured in a fibrin 
gel increased the expression of differentiation-associated 
genes as compared to monolayer culture.33 Our study con-
firms this finding, showing early formation of myotubes and 
upregulation of differentiation-associated proteins in myo-
blasts cultured in fibrin gel. This differentiation was obtained 
without the use of DM, thus induced by the conditions in the 
fibrin. While myoblasts embedded deeper inside the gel dif-
ferentiated into myotubes, we, in addition, found a popula-
tion of proliferating cells located on the surface of the gel. 
Moreover, myoblasts released from degrading fibrin gel 
were able to proliferate in monolayer culture, and they had 
retained their capability to fuse into myotubes. This indicates 
that the fibrin gels besides the postmitotic, differentiating 
cells harbored a population of cells with proliferative capac-
ity. Distance to surface and number of cells are important 
parameters in models for estimating availability of nutrition 
and oxygen in scaffolds.36 Moreover, the method to induce 
myoblast differentiation in vitro28 includes a reduction in the 
serum content and the amount of insulin (or insulin-like 
growth factor (IGF)) in the medium. A reduced supply of 
nutrients and growth factors in the scaffold thus could be fac-
tors contributing to the observed differentiation.
The fibrin gel has myotubes located centrally, and prolif-
erating myoblasts located at the surface. Consequently, the 
fibrin gel offers the possibility that proliferating myoblasts 
in the surface of the gel in vivo could promote the fusion of 
myotubes formed in the gel with existing myofibers.
Alginates are linear polysaccharides composed of vary-
ing proportions of mannuronic and guluronic acid. By addi-
tion of a polyvalent cation, such as calcium, the alginate will 
polymerize and form a gel. The ratio of guluronic acid to 
mannuronic acid affects mechanical strength and porosity of 
the gel. A study showed that primary murine myoblasts 
embedded in alginate gel have a round shape, and that they 
lack the ability to differentiate, while the ability to prolifer-
ate depended on the stiffness and degradability of the gel.37 
Alginate has also been suggested as an alternative to cryo-
preservation for the short-term storage of stem cells.38
In our study, the myoblasts cultured in a 1% LVG algi-
nate gel within 96 h had a rounded morphology and did not 
express proliferation or differentiation markers indicating 
that alginate gel induced quiescence of the myoblasts.
It has been shown that the stiffness of the substrate influ-
ences the cell state of myoblasts,37,39,40 and we have previ-
ously found that primary human myoblasts entered 
quiescence when cultured in a high-viscosity medium for 
96 h.27 Similarly, a 0.7% LVG alginate surface has been 
reported not to support attachment of C2C12 mouse myo-
blasts.32 Lack of cell binding motifs in alginate has also 
been addressed in context of cell adhesion and morphology. 
Thus, RGD (arginine-glycine-aspartate-peptide)-modified 
alginates were reported to support attachment of C2C12 
myoblasts in two-dimensional (2D) cultures, but did not 
have a clear effect on survival or growth pattern of the cells 
in three-dimensional (3D) cultures.32 Cytoskeletal arrange-
ment is an important factor for transmitting signals to the 
nucleus, and it has been shown that blocking intracellular 
adhesion–dependent signals mimics absence of adhesive 
contacts. Rounding up of the cells is also seen here and 
correlates with quiescence,41,42 indicating a molecular 
mechanisms behind alginate induced quiescence.
When the myoblasts were released from degrading algi-
nate gel, their ability to fuse into myotubes was retained, 
and when compared to myoblast released from fibrin gel, 
they had an ability to form larger tubes with a higher num-
ber of nuclei. Moreover, it seems that more cells were 
spontaneously released from alginate than from fibrin gel. 
One reason for this could be that part of the cells released 
from the fibrin gel had already differentiated, while the 
cells in the alginate gel were still able to adhere and prolif-
erate. When alginate gel after 4 days was quickly dissolved 
by calcium chelation, the retrieval of cells was much larger 
than what was observed from spontaneously degrading 
alginate gels in culture medium.
In vivo, an injury will result in a local, synchronous 
activation of myogenic stem cells.1 The synchronous 
release and reactivation of myoblasts from quickly dis-
solved gels mimic the induction of regeneration after a 
lesion. Thus, in our in vitro study on activation of primary 
human myoblasts, we found that the cells synchronously 
progressed in the myogenic program.27 Considering this, 
in a clinical setting, it could be advantageous to inject 
myoblasts in alginate, and later, when they have entered 
quiescence, to dissolve the gel with a calcium chelator.
In this study, we cultured primary human myoblast on 
PLGA microparticles with a diameter ranging from 10–
100 µm. In a previous comparable study, primary human 
myoblasts were cultured on porous PLGA microspheres 
with a diameter ranging from 250–425 µm.43 In both stud-
ies, the PLGA promoted continuous proliferation of myo-
blasts and prevented spontaneous differentiation. However, 
with our choice in particle size, cells are able to attach to 
more particles and thus form larger structures of cell-parti-
cle aggregates. This could be advantageous for subsequent 
muscle formation, having many myoblasts kept in close 
proximity by attachment to particles. A disadvantage of 
using microparticles for cell delivery could be that in con-
trast to hydrogels, the microparticles may offer less protec-
tion against a hostile environment in vivo. However, cells 
located in the interior of larger aggregates are likely to be 
shielded. In this connection, it can also be mentioned that 
transplanted myofibers with adherent myoblasts in mice 
have been shown to be successful. In that case, the myo-
blasts were also situated on a surface, here of the implanted 
fibers, and thus survived and proliferated extensively 
10 Journal of Tissue Engineering 
without a protective coverage.44 The size of particles we 
chose in our study forms chains of cell-particle aggregates 
with dimensions resembling those of muscle fibers, which 
in vivo could be an advantage, simulating the implantation 
of fibers. During degradation, PLGA releases acidic mon-
omers. These could be locally harmful, which calls for 
minimizing the amount of material.
In our in vitro cultured gels, the organization of myo-
tubes was random. However, it has been shown that when a 
strain is applied to myoblasts cultured in fibrin gel, they 
align in the direction of the strain.45 This has been further 
developed into bioengineered muscle constructs able to 
generate contractile force upon electrical stimulation.34,46 
Similarly, implantation of fibrin containing material embed-
ded with mesangioblasts underneath the skin upon the tibi-
alis anterior muscle in mice created aligned myofibers in the 
construct.47 This suggests that when integrated in muscle in 
vivo, the organization of muscle formed in implanted hydro-
gel scaffolds will be induced by the direction of tension. 
Similarly, the myoblasts in the PLGA-cell aggregates in 
vivo would be exposed to stretch. More generally, cells and 
scaffolds in vivo will be exposed to dynamic loading, and it 
has been reported that dynamic loading can influence both 
the formation of tissue and the degradation of scaffolds.48–50 
The impact appears to be cell-type dependent, and besides 
the effect of stretch, little is known concerning myogenic 
cells. Regarding the impact on scaffolds, the degradation of 
polycaprolactone (PCL) and PLGA has been found to be 
faster when exposed to dynamic loading. The final rate of 
degradation in vivo, however, is determined by the com-
bined influence of physical and biological conditions.
In this study, we show that cell state can be included as an 
element for the optimization of myoblast transplantation.
The degradability of the three injectable scaffold mate-
rials employed in this study can be controlled. In addition, 
the hydrogels can be formulated to obtain different stiff-
ness. Cell concentration, degradation, and gel stiffness all 
affect cell state. This means that there are many options for 
directing the myoblast toward a specific cell state. As an 
element in the development of implantation procedures, 
some of the cell instructive effects of scaffolds can be stud-
ied in vitro. Performing immunochemistry on myoblasts 
cultured with scaffold materials in vitro, before using them 
for in vivo experiments, is an informative and simple first-
step strategy to screen the effects on cell behavior, mor-
phology, and distribution in the materials.
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